SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-259451
Filing Date
2021-08-27
Accepted
2021-08-27 17:02:12
Documents
13
Period of Report
2021-08-25
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d173361d8k.htm   iXBRL 8-K 26696
2 EX-10.1 d173361dex101.htm EX-10.1 61957
  Complete submission text file 0001193125-21-259451.txt   226821

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA aveo-20210825.xsd EX-101.SCH 2904
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE aveo-20210825_lab.xml EX-101.LAB 17374
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aveo-20210825_pre.xml EX-101.PRE 10961
6 EXTRACTED XBRL INSTANCE DOCUMENT d173361d8k_htm.xml XML 3271
Mailing Address 30 WINTER STREET BOSTON MA 02108
Business Address 30 WINTER STREET BOSTON MA 02108 857-400-0101
AVEO PHARMACEUTICALS, INC. (Filer) CIK: 0001325879 (see all company filings)

IRS No.: 043581650 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34655 | Film No.: 211219935
SIC: 2834 Pharmaceutical Preparations